Literature DB >> 9013311

The change in tenascin expression in mouse uterus during early pregnancy.

H Kida1, M Taga, H Minaguchi, M Hanazono, T Ohashi, T Sakakura, M Kusakabe.   

Abstract

PURPOSE: Our aim was to examine the changes in spatiotemporal tenascin (TN) expression in mouse uterus during early pregnancy, when the uterine tissue undergoes a tremendous restructuring.
METHODS: Using immunohistochemistry and in situ hybridization, the changes in distribution of TN protein in mouse uterine tissues in pregnancy Day 0 through Day 5 were analyzed.
RESULTS: Immunoreactive TN and TN mRNA were expressed in the basement membrane of the epithelium as well as in the smooth muscle layer, and their distribution shifted from the subbasement region on Day 0-3 to the smooth muscle layer on Days 4 and 5.
CONCLUSIONS: These results indicate that TN expression in the uterus during early pregnancy is spatiotemporally different and may be regulated by a different mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013311      PMCID: PMC3454707          DOI: 10.1007/bf02765752

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  16 in total

1.  Isolation and characterization of human fibroblast tenascin. An extracellular matrix glycoprotein of interest for developmental studies.

Authors:  Y Oike; H Hiraiwa; H Kawakatsu; M Nishikai; T Okinaka; T Suzuki; A Okada; R Yatani; T Sakakura
Journal:  Int J Dev Biol       Date:  1990-06       Impact factor: 2.203

Review 2.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors.

Authors:  H P Erickson; M A Bourdon
Journal:  Annu Rev Cell Biol       Date:  1989

3.  Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts.

Authors:  R Chiquet-Ehrismann; P Kalla; C A Pearson
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

4.  Tenascin expression in the human endometrium and in endometrial adenocarcinomas.

Authors:  G Vollmer; G P Siegal; R Chiquet-Ehrismann; V A Lightner; H Arnholdt; R Knuppen
Journal:  Lab Invest       Date:  1990-06       Impact factor: 5.662

5.  Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma.

Authors:  J E Ferguson; A M Schor; A Howell; M W Ferguson
Journal:  Differentiation       Date:  1990-02       Impact factor: 3.880

Review 6.  What distinguishes tenascin from fibronectin?

Authors:  R Chiquet-Ehrismann
Journal:  FASEB J       Date:  1990-06       Impact factor: 5.191

7.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis.

Authors:  Y Inaguma; M Kusakabe; E J Mackie; C A Pearson; R Chiquet-Ehrismann; T Sakakura
Journal:  Dev Biol       Date:  1988-08       Impact factor: 3.582

8.  Immunohistological localization of tenascin in the human endometrium.

Authors:  M Yamanaka; M Taga; H Minaguchi
Journal:  Gynecol Obstet Invest       Date:  1996       Impact factor: 2.031

9.  Action of angiotensin II on the electrical and mechanical activity of rat uterine smooth muscle.

Authors:  J Mironneau; C Mironneau; A Grosset; G Hamon; J P Savineau
Journal:  Eur J Pharmacol       Date:  1980-12-05       Impact factor: 4.432

10.  Tenascin: cDNA cloning and induction by TGF-beta.

Authors:  C A Pearson; D Pearson; S Shibahara; J Hofsteenge; R Chiquet-Ehrismann
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  2 in total

Review 1.  The role of extracellular matrix in normal and pathological pregnancy: Future applications of microphysiological systems in reproductive medicine.

Authors:  Blakely B O'Connor; Benjamin D Pope; Michael M Peters; Carrie Ris-Stalpers; Kevin K Parker
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-08

2.  Endometrial gene expression profiling of recurrent implantation failure after in vitro fertilization.

Authors:  İrem Gülfem Albayrak; Fatemeh Azhari; Ezgi Nur Çolak; Burçin Karamustafaoğlu Balcı; Ege Ülgen; Uğur Sezerman; Ercan Baştu; Tuba Günel
Journal:  Mol Biol Rep       Date:  2021-07-03       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.